Effect of prostaglandins and aspirin on active E-rosette formation in patients with multiple sclerosis.
D000328:Adult; D000368:Aged; D000527:Alprostadil; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001241:Aspirin / Q000494:pharmacology*; D002493:Central Nervous System Diseases / Q000276:immunology; D000242:Cyclic AMP / Q000096:biosynthesis; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology*; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D012397:Rosette Formation
D011453:Prostaglandins; D011458:Prostaglandins E; D000242:Cyclic AMP; D000527:Alprostadil; D015232:Dinoprostone; D001241:Aspirin